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Background: TPCs are regulated by NAADP and other factors.
Results: NAADP-induced Ca2 release from acidic stores evokes depolarizing currents in pancreatic  cells. Inhibition of
NAADP signaling or TPC knock out attenuates Ca2 signaling and insulin secretion.
Conclusion: NAADP-evoked Ca2 release enhances  cell excitability and insulin secretion in response to glucose or
sulfonylureas.
Significance: NAADP signaling pathways offer novel therapeutic targets for diabetes treatment.
Pancreatic  cells are electrically excitable and respond to
elevated glucose concentrations with bursts of Ca2 action
potentials due to the activation of voltage-dependent Ca2
channels (VDCCs), which leads to the exocytosis of insulin gran-
ules. We have examined the possible role of nicotinic acid ade-
nine dinucleotide phosphate (NAADP)-mediated Ca2 release
from intracellular stores during stimulus-secretion coupling in
primary mouse pancreatic  cells. NAADP-regulated Ca2
release channels, likely two-pore channels (TPCs), have recently
been shown to be a major mechanism for mobilizing Ca2 from
the endolysosomal system, resulting in localized Ca2 signals.
We show here that NAADP-mediated Ca2 release from en-
dolysosomal Ca2 stores activates inward membrane currents
and depolarizes the  cell to the threshold for VDCC activation
and thereby contributes to glucose-evoked depolarization of the
membrane potential during stimulus-response coupling. Selec-
tive pharmacological inhibition ofNAADP-evokedCa2 release
or genetic ablation of endolysosomal TPC1 or TPC2 channels
attenuates glucose- and sulfonylurea-induced membrane cur-
rents, depolarization, cytoplasmic Ca2 signals, and insulin
secretion. Our findings implicate NAADP-evoked Ca2 release
from acidic Ca2 storage organelles in stimulus-secretion cou-
pling in  cells.
Pancreatic cells are electrically excitable, and in response to
elevated blood glucose concentrations, oscillatory bursts of
Ca2 action potentials mediated by VDCCs5 are elicited. These
drive cytosolic Ca2 ([Ca2]i) oscillations that, in turn, induce
pulsatile insulin release (1), and defects in their generationmay
be associated with the loss of glucose homeostasis in type-2
diabetes (2). Glucose-evoked membrane depolarization results
from the closure of ATP-dependent potassium (KATP) chan-
nels, octameric complexes of sulfonylurea receptor 1 (SUR1)
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and inwardly rectifying Kir6.2 potassium channel subunits (3),
and inactivating or activating mutations in the KATP channel
(where the KATP channel is the ATP-dependent potassium
channel) subunits lead to congenital hyperinsulinemia (4) or
neonatal diabetes (5), respectively. However, KATP channel clo-
sure alone is not sufficient to depolarize the membrane to
threshold, and activation of an additional depolarizing current
has also been postulated (6, 7). The existence of an additional
glucose-regulated membrane current in  cells is suggested by
the finding that mice lacking functional KATP channels (8), like
Sur1 or Kir6.2 knock-out mice), are not hypoglycemic, and
islets from adult knock-out mice are still capable of responding
to glucosewith electrical activity, [Ca2]i oscillations, and insu-
lin secretion (9–11). The identity and regulation of this mem-
brane conductance remain an enigma.
In contrast to the Ca2 influx across the plasma membrane
that plays a critical role in effecting insulin granule exocytosis,
Ca2 release from intracellular stores has been thought to play
amodulatory rather than a triggering role in stimulus-secretion
coupling in the pancreatic  cell. [Ca2]i oscillations in
response to glucose are modulated by the uptake and release of
Ca2 from endoplasmic reticulum (ER) Ca2 stores (12) and
also from acidic Ca2 storage organelles (13). In addition, sev-
eral incretins, such as glucagon-like peptide 1 and acetylcho-
line, are thought to enhance insulin secretion by mechanisms
that are, in part, dependent on Ca2 release from intracellular
stores via intracellular messengers such as cAMP and inositol
trisphosphate (IP3) (14, 15). However, recent studies have sug-
gested that the newly discovered Ca2-mobilizing messenger
NAADP might play an important role in  cell Ca2 signaling
(16–24).
NAADP, the most potent of the Ca2-mobilizing messen-
gers described, has been shown tomediate local Ca2-signaling
events by releasing Ca2 from acidic, endolysosomal Ca2
stores in several vertebrate and invertebrate cells (25–27), and
appears to be a critical trigger for many Ca2-signaling events
(26–28). The most prominent target Ca2 release channels for
NAADP have recently been identified as the two members of
the endolysosomal two-pore channel family, TPC1 and TPC2
(29–37). Some studies report a lack of NAADP sensitivity in
isolated lysosomes (23, 38), which may reflect technical issues,
but also may be due in part to loss of NAADP binding to an
accessory protein (39–42) forming part of a multiprotein sig-
naling complex in endolysosomal membranes (27, 43–45).
NAADP-induced Ca2 release in MIN6 cells can be disrupted
by the lysomotropic agent glycyl-L-phenylalanine--naphthyl-
amide (GPN) or bafilomycin, which disrupts acidic store Ca2
storage implicating lysosomally related organelles as the prin-
cipal target for NAADP in these cells (19, 20, 23). In the pan-
creatic  cell line MIN6, and primary mouse  cells, glucose
increases NAADP synthesis and hence intracellular levels (18,
20, 22), consistent with its role as an intracellular messenger.
NAADP introduced into mouse pancreatic  cells via a patch
pipette was found to evoke a series of oscillatory plasma mem-
brane currents, which were blocked by the NAADP antagonist
Ned-19 (21) and were abolished in pancreatic  cells prepared
from Tpcn2/mice (29). Furthermore, increasing concentra-
tions of Ned-19 abolished glucose-evoked Ca2 spiking in
mouse pancreatic  cells, suggesting an important role for
NAADP in stimulus-response coupling in these cells (21). This
finding is consistent with our earlier study showing that prior
desensitization of NAADP-sensitive Ca2 release mechanisms
block subsequent glucose-evoked Ca2 signals in MIN6 cells
(18).
Glucose (18) and glucagon like-peptide 1 (18, 20) have both
been reported to increase  cell NAADP levels, effects thatmay
be partially dependent on the ADP-ribosyl cyclase, CD38 (20,
22). At present, ADP-ribosyl cyclases, including CD38, are the
only characterized enzymes that have been demonstrated to
catalyze the synthesis of NAADP, using NADP and nicotinic
acid as substrates by a base-exchangemechanism (46, 47). It has
been suggested that glucose stimulation increases the internal-
ization of CD38 involving cytoskeletal changes (22) with
NAADP synthetic sites associated with acidic organelles (20).
Furthermore, glucose-evoked Ca2 signals and insulin secre-
tion are impaired in mouse Cd38/ pancreatic  cells, and
Cd38/mice showglucose intolerance (48), andhumanCD38
autoantibodies and CD38 mutations have been shown to be
associated with type-2 diabetes (49, 50). Recently, extracellular
NAADP was found to be transported into mouse pancreatic 
cells where it evoked Ca2 release from acidic stores (24).
Remarkably, intraperitoneal injections of NAADP were found
to restore glucose-evoked insulin secretion in the db/dbmouse
model of type-2 diabetes and to ameliorate blood glucose reg-
ulation (24).
Here, we have used the cell-permeant analogue of NAADP,
NAADP-AM (51), the selective cell-permeant NAADP antag-
onist Ned-19 (21), Tpcn1/ and Tpcn2/ mice (29), to
explore a possible role for TPC-dependent NAADP-induced
Ca2 release from acidic stores in glucose-induced [Ca2]i
increases and insulin secretion in primary mouse  cells.
Experimental Procedures
Preparation of Islets of Langerhans and Islet Cell Clusters—
Islets of Langerhans were aseptically isolated by collagenase
digestion of the pancreases of 8–10-week-old male mice of the
following strains: CD1, Tpcn2/ and Tpcn2/ (29),
Tpcn1/ andTpcn1/ (52), withTpcnmice in a B6;129 back-
ground. All mice were killed by cervical dislocation and age-
and sex-matched (and for the latter two, background strain-
matched). Except for the hormone release measurements (for
which intact islets were used), clusters of islet  cells and single
 cells were prepared by dispersing islets in a Ca2-free
medium and cultured on circular coverslips for 1–4 days in
RPMI 1640 culture medium (GIBCO, Paisley, UK) containing
10% heat-inactivated fetal calf serum, 100 IU/ml penicillin, 100
g/ml streptomycin, and 10 mM glucose.
[Ca2]i Measurements—Cultured clusters of islet cells were
loaded with 1M Fura PE3-AMor Fura 2-AM (Teflabs, Austin,
TX) for 60min at 37 °C in a bicarbonate-buffered solution con-
taining 10 mM glucose. The coverslip was then used as the bot-
tom of a temperature-controlled perifusion chamber (Biosci-
ence Tools, San Diego) mounted on the stage of an inverted
microscope. The flow ratewas 1.5ml/min, and the temperature
within the chamber was 37 °C. [Ca2]i was measured at dual-
wavelength (340 and 380 nm) excitation spectrofluorimetry,
NAADP-mediated Ca2 Release in Pancreatic Cells
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using a CCD camera (Photon Technologies International,
Princeton, NJ) to capture the emitted fluorescence at 510 nm.
When [Ca2]i was simultaneously measured in a voltage-
clamped single cell, the patch pipette contained 100 M Fura 2
pentapotassium salt, and the emitted fluorescence was cap-
tured at 510 nm using a photomultiplier (Photon Technologies
International, Princeton, NJ).
Measurement of Flavine Adenine Dinucleotide (FAD)
Fluorescence—Cultured clusters of  cells were preincubated
for 60 min at 37 °C in a control medium containing 3 mM glu-
cose and then transferred to the stage of an LSM 510 confocal
microscope. After a further 10 min of perfusion by 3 mM glu-
cose, the recording was started. The oxidized form of the FAD
was excited at 488 nm. Emitted fluorescence was collected with
a 505-nm long-pass filter.
Electrophysiology—All patch clamp measurements were car-
ried out using amulticlamp 700B patch clamp amplifier and the
software pClamp 9 (Axon Instruments, Foster City, CA).When
using the perforated whole-cell mode of the patch clamp tech-
nique, the electrical contactwas established by adding the pore-
forming antibiotic, amphotericin B, to the pipette solution.
Amphotericin (stock solution of 60 mg/ml in DMSO) was used
at a final concentration of 300g/ml. The tip of the pipette was
filled with antibiotic-free solution, and the pipette was then
back-filled with amphotericin-containing solution. The voltage
clamp was considered satisfactory when the access resistance
was30 megohms and stable. In the standard whole-cell con-
figuration, the access resistance was 15 megohms. Patch
pipettes were pulled from borosilicate glass capillaries (World
Precision Instruments, Hertfordshire, UK); they had resis-
tances of 3–5 megohms when filled with intracellular solution.
All experiments were carried out on single  cells. Two cri-
teria were used to identify  cells. The capacitance ofmouse -,
-, and  cells has been reported to be 4.4, 5, and 7.4 picofarads,
respectively. Therefore, only large cells with a capacitance of
5 picofarads were chosen for this study. The average capaci-
tance was 7.6 0.2 picofarads. After verification of the capac-
itance, a depolarizing protocol was applied to identify the
properties of the voltage-dependent Na current, which is
known to be largely inactivated at resting potential in  cells
but not in and  cells. Thus, cells in which a largeNa current
could be activated by a small depolarizing pulse from a holding
potential of 70 mV were discarded. By contrast, cells that
displayed a Na current only after a hyperpolarizing pulse to
140 mV were considered to be  cells and were used for the
experiments.
The whole-cell KATP channel current (IK(ATP)) was moni-
tored by 100-ms duration pulses of 20 mV from a holding
potential of70 mV.Whole-cell Ca2 currents were recorded
by depolarizing the plasma membrane with a 100-ms pulse
from80 to 10 mV.
Solutions—The medium used for the isolation of islets and
for all experiments was a bicarbonate-buffered solution con-
taining (in mM) the following: 120 NaCl, 4.8 KCl, 2.5 CaCl2, 1.2
MgCl2, and 24 NaHCO3. It was gassed with O2/CO2 (94:6) to
maintain pH 7.4 at 37 °C. Except for the electrophysiological
experiments, it was supplemented with 1 mg/ml BSA (fraction
V, Roche Applied Science, Mannheim, Germany). When the
concentration of KCl was increased, the concentration of NaCl
was correspondingly decreased to keep the osmolarity of the
medium unchanged.
For electrophysiological measurements of IK (ATP), the stan-
dard extracellular solution contained (inmM) the following: 140
NaCl, 4.8 KCl, 2.5 CaCl2, 1.2 MgCl2, 5 HEPES (pH adjusted to
7.40 with NaOH), and 10 mM glucose. These solutions were
gassedwithO2/CO2 (94:6%). For the perforated patchmeasure-
ments ofmembrane currents and potential, the pipette solution
contained (inmM) the following: 70K2SO4, 10NaCl, 10KCl, 3.7
MgCl2, and 5HEPES (pH adjusted to 7.1 with KOH). For whole
Ca2 current, the pipette solution consisted of (in mM) the fol-
lowing: Cs2SO4 substituted for K2SO4. For NAADP infusion
experiments, the pipette solution contained (inmM) the follow-
ing: 125 K gluconate, 10 KCl, 10 NaCl, 10 KCl, 1 MgCl2, 3
Mg-ATP, 0.1 Na-GTP, and 5 HEPES (pH adjusted to 7.1 with
KOH). In Fig. 3A, 100 M Fura 2 pentapotassium was added.
Gene Expression Analysis—Total RNA was extracted from
mice pancreas and liver following the RNeasy QiaRNA extrac-
tion procedure, including a DNase treatment (Qiagen).
RT-PCR was performed in a reaction containing extracted
RNA, the SuperScriptII One-Step RT-PCR system with Plati-
numTaq (Invitrogen), and the following gene-specific primers:
Tpcn2 exons 4–8 amplicon (forward, 5-gggcttcatcattttcctga-
3; reverse, 5-ttgttggaagtcgtcagcag-3). The following parame-
ters were used for RT: 50 °C (30 min), 94 °C (2 min); PCR, 30
cycles of 94 °C (15 s), 57 °C (30 s), and 68 °C (1min), followed by
a final extension at 68 °C (10min). For gene expression analysis
in  cells, cDNA was produced from total RNA using the High
Capacity cDNA reverse transcription kit (Applied Biosystems),
and PCRwas performed with the following gene-specific prim-
ers forTpcn2 exons 22–25 amplicon (forward, 5-aacgtgatggtg-
gtgaacaat-3; reverse, 5-gtctgccaaagctacaccttg-3). The follow-
ing parameters were used for PCR: 30 cycles of 95 °C (30 s),
53 °C (30 s), and 72 °C (1 min), followed by a final extension at
72 °C (10 min). Tpcn1 mRNA expression was analyzed as
described previously (52).
Insulin Secretion—Islets were isolated from mice and cul-
tured in RPMI 1640medium overnight before insulin secretion
was assessed. Insulin secretion was measured during 1-h static
incubations in Krebs-Ringer Buffer (KRB) containing (in mM)
the following: 18.5NaCl, 2.54CaCl2, 1.19 KH2PO4, 4.74 KCl, 25
NaHCO3, 1.19 MgSO4, and 10 HEPES (pH 7.4). Samples of the
supernatant were assayed for insulin using a mouse insulin
ELISA kit (Mercodia, Sweden). Where Ned-19 was used, islets
were preincubated for 5min with the drug prior to the addition
of secretagogues.
Glucose Tolerance Tests—Male Tpcn1/ (Tpcn1tm1Dgen)
(52) and Tpcn2/ (Tpcn2Gt(YHD437)Byg) (29) mice and strain-
matched wild types aged 66–76 days were fasted overnight and
then given 2 g/kg intraperitoneal glucose (in the form of an
autoclaved 20% glucose solution). Blood samples taken from
the tail vein at 0, 15, 30, 60, and 120 min were analyzed with an
Accu-Chek Compact Plus glucose monitor. Mean values for
each time were compared using the Student’s t test, with p 
0.05 taken as significant.
Insulin Secretion from Whole Pancreata—Pancreatic perfu-
sions were performed within 15 min of cervical dislocation in
NAADP-mediated Ca2 Release in Pancreatic Cells
21378 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 35•AUGUST 28, 2015
 at O
PEN
 U
N
IV
ERSITY
 on A
ugust 28, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
80–100-day-old mice essentially as described elsewhere (53).
At the end of the perfusion, the pancreas was dissected and
transferred in acid/ethanol (ethanol/H2O/HCl, 52:17:1). All
samples were then stored at20 °C. Only experiments with an
output rate greater than 200 ml/min were assayed for insulin.
The hormone assay was done using a commercially available
RIA kit (Millipore, Watford, UK).
TPC2 Localization Studies—Human islets were prepared
from beating heart donors with appropriate ethical permission
and consents as described previously (54). Islets were dissoci-
ated into single cells and, after fixation in 4% (w/v) paraformal-
dehyde, were treated with antibodies as below (55). Rabbit anti-
TPC2 antibody (1:150) was revealedwithAlexa 568-conjugated
secondary antibody (1:1500, Invitrogen, Paisley, UK). Guinea
pig anti-insulin (1:300, DAKO, Ely, UK), goat anti-EEA1 (1:150,
Santa Cruz Biotechnology, Santa Cruz, CA), and rat anti-
LAMP-1 (1:150, Santa Cruz Biotechnology) were revealed with
Alexa 488 secondary antibodies (1:1500, Invitrogen). Murine
MIN6 clonal  cells (56) were transfected with plasmid encod-
ing TPC2-mCherry using Lipofectamine 2000, and 48 h later
were fixed, stained, and imaged as above. Images were captured
using a Zeiss Axiovert 200 M spinning disc confocal imaging
system (40 oil immersion objective corrected for chromatic
aberration; Hamamatsu ImageEM 9100-13 back-illuminated
EM-CCD camera) with illumination (491 and 568 nm) pro-
vided by solid state lasers (Crystal Laser, NV) using a laser
merge module (Spectral Applied Physics, Ontario, Canada)
(57).
ElectronMicroscopy—The islet preparations were fixed in 2%
paraformaldehyde and 2% glutaraldehyde in cacodylate buffer
in the presence of calcium chloride, washed, post-fixed in 1%
osmium tetroxide, and contrast-enhanced by staining en bloc
with uranyl acetate. Sections were further contrasted with
Reynold’s lead.
Chemicals—Ned-19, Ned-20 (21), and NAADP-AM (51)
were synthesized in-house as described previously. Bafilomycin
was from LC Laboratories, and other chemicals were from
Sigma.
Results
Characterization of NAADP-AM-evoked Ca2 Release—We
first investigated the effects of NAADP on intracellular Ca2
concentrations ([Ca2]i) in primary mouse pancreatic  cells
using the membrane-permeant NAADP analogue NAADP-
AM (51). Given that the concentration-response curve is bell-
shaped in mammalian cells (58), different NAADP-AM con-
centrations were tested to optimize the response (Fig. 1A) (58).
10 nM NAADP-AM gave only a small response, whereas 10 M
NAADP-AM gave no response at all. An intermediate concen-
tration of 60 nM was found to give the most consistent and
largest Ca2 response and was used for subsequent studies.
In 8/10 clusters of  cells, extracellular application of
NAADP-AM (60 nM), in the presence of low glucose (3 mM),
evoked delayed [Ca2]i increases (Fig. 1A). The peak was
reached15min after application ofNAADP-AM (Fig. 1F). To
assess the role of the ER in the action of NAADP-AM (59), we
treated the cells with the SERCA pump inhibitor thapsigargin
in the absence of extracellular Ca2 to remove functional ER
Ca2 stores. In keeping with earlier observations (13), the
NAADP-AM-evoked [Ca2]i transients were larger and
occurredmore rapidly after thapsigargin treatment (Fig. 1,B, E,
and F) (13). Previous studies have implicated acidic Ca2 stores
as the principal target organelles for NAADP in pancreatic 
cells and other cells (19, 60). Accordingly, bafilomycin (which
inhibits Ca2 uptake into acidic stores dependent on V-H-
ATPase activity (60)) blocked Ca2 release in response to
NAADP-AM treatment (Fig. 1,C and E). In addition, themem-
brane-permeant NAADP antagonist Ned-19 (100 M) (Fig. 2F)
(21) also completely abolished the Ca2 transient evoked by
NAADP-AM (Fig. 1, D and E). Collectively, these data suggest
that NAADP targets acidic Ca2 stores rather than the ER in
mouse pancreatic  cells.
Modulation of Glucose-evoked Ca2 Spiking by Ned-19 and
Vacuolar Proton Pump Inhibitors—Wenext examinedwhether
NAADP signaling plays a role in glucose-mediated responses in
primary  cells as suggested previously in MIN6 cells (18).
Stimulation of mouse pancreatic  cells by 10 mM glucose
resulted in [Ca2]i oscillations that were superimposed upon a
sustained plateau (Fig. 2A). Acute application of 60 nM
NAADP-AM first enhanced Ca2 spiking from 5.8  0.7 to
11.6  1.3 spikes/min (n 	 5; p  0.01) and then abolished
glucose-evoked [Ca2]i oscillations after about 20–25min (Fig.
C
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FIGURE 1. NAADP mobilizes Ca2 from acidic Ca2 stores in mouse pri-
mary  cells. A, clusters of  cells were superfused with 3 mM glucose and
stimulated by NAADP-AM, 10 nM (red line), 60 nM (black line), and 10 M (blue
line), and glucose (10 mM) as indicated. B, clusters of  cells were pre-treated
with 1M thapsigargin (TG) for 1 h. Theywere then stimulated byNAADP-AM
(60 nM) in the absence of extracellular Ca2 and in the presence of a non-
stimulatory glucose concentration (3 mM). C, NAADP-AM-induced [Ca2]i
response observed in B is prevented by bafilomycin (Baf, 3 M) treatment. D,
pretreatment of cells with Ned-19 (100M) blocks the NAADP-AM-induced
[Ca2]i rise observed in B. E and F, quantification of the results from A to D.
Traces are representative of results obtained in 8 (A), 7 (B), 6 (C), and 6 (D)
clusters of islet  cells.
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2B). This finding is consistent with the bell-shaped concentra-
tion-response curve toNAADP inmammalian cells (18, 51, 61);
the initial stimulatory effect was mediated by low concentra-
tions, and the subsequent inhibition reflected the build-up of
higher self-desensitizing concentrations of NAADP (16, 18).
The antagonist (18, 51, 61) Ned-19was also found to inhibit the
glucose-induced [Ca2]i rise, and it abolished the Ca2 oscilla-
tions, without affecting the initial [Ca2]i decrease due to ATP-
enhanced Ca2 uptake by the ER (Fig. 2C) (62). When Ned-19
was applied after commencement of glucose-evoked Ca2
responses, the glucose-induced [Ca2]i plateau was abolished
(Fig. 2D). The structurally related analogue Ned-20, which is
not an NAADP antagonist (Fig. 2G) (21), was without effect
(Fig. 2E).
BecauseNAADPmobilizedCa2 from acidic organelles (Fig.
1C) (60), we examined whether selective pharmacological
interference of Ca2 storage by acidic organelles with agents
that affect Ca2 uptake into these stores (60) modulates glu-
cose-evoked Ca2 signaling. Preincubation of  cells with bafi-
lomycin prevented the glucose-induced [Ca2]i rise (Fig. 2H),
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FIGURE 2. Glucose-induced [Ca2]i response in pancreatic  cells are dependent on NAADP-evoked Ca
2 release from acidic stores. A, typical [Ca2]i
oscillations induced by the stimulation of clusters of islet  cells by an increase of glucose from 3 to 10 mM as indicated. B, clusters of  cells were challenged
with 10mM glucose, and NAADP-AM (60 nM) was added acutely as indicated. C, clusters of islet  cells were challenged with 10mM glucose in the continuous
presence of Ned-19. High Kwas applied as indicated.D, clusters of cells were stimulated by an increase of glucose from3 to 10mMglucose, andNed-19was
appliedacutely as indicated. E, clusters of cellswere stimulatedbyan increaseof glucose from3 to10mM, andNed-20was addedas indicated. Representative
trace was obtained in five separate clusters of islet  cells. F and G, structures of Ned-19 and Ned-20, a close structural analogue in which the fluorine atom is
para on thebenzene ring.H, clusters of islet cellswere pretreatedwith 3Mbafilomycin and challengedwith glucose or K (45mM) as indicatedbyhorizontal
bars (by opening the KATP channels, diazoxide (Dz) (100 M) prevents the direct effect of glucose on the membrane potential). I, glucose-induced [Ca
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oscillations are reversibly abolished by acute addition of 3 M bafilomycin (Baf). J, quantification of the frequency of [Ca2]i oscillations in I. K, clusters of
pancreatic  cells were challenged with 10mM glucose, and concanamycin (6M) was added acutely as indicated by the horizontal bar. The trace is represen-
tative of results obtained from eight clusters of islet cells. Other traces are representative of results obtained in 11 (A), 5 (B), 8 (C), 9 (D), 8 (H), and 10 (I) clusters
of islet  cells (*, p 0.05, Student’s t test).
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as observed previously in the MIN6  cell line (19). When bafi-
lomycin was applied acutely, it reduced glucose-induced
[Ca2]i oscillations (Fig. 2I). Similar results were obtained with
concanamycin, another V-type-H-ATPase blocker (Fig. 2K).
The effect of bafilomycin on the frequency of glucose-evoked
[Ca2]i transients is summarized in Fig. 2J. These observations
are consistentwith the hypothesis thatNAADP-sensitive acidic
Ca2 stores play a key role in sustaining glucose-induced
[Ca2]i oscillations in mouse pancreatic  cells (63).
NAADP Modulation of Plasma Membrane Currents and
Membrane Potential—Wehave previously shown that intracel-
lular application of NAADP in  cells evokes oscillatory cur-
rents (21, 29). To examine the impact of NAADP-evoked Ca2
release on the excitability of pancreatic  cells in more detail,
we infusedNAADP (10–100 nM) through a patch pipette in the
standard whole-cell configuration while simultaneously mea-
suring the membrane currents. In  cells clamped at70 mV,
intracellular application of 100 nM NAADP evoked intermit-
tent inward currents of varying amplitudes (Fig. 3A). These
currents contrast with the periodic outward hyperpolarizing
K currents evoked by IP3-evoked Ca2 release in  cells (64),
and they underscore the differential actions of these two Ca2-
mobilizing messengers. The inward currents were absent in
control cells where no NAADP was added to the intracellular
solution (Fig. 3B), as well as when highly desensitizing concen-
trations (1 M) of NAADP were used (Fig. 3C), consistent
with the bell-shaped concentration-response curve due to self-
desensitization of the NAADP receptor (18, 61). Moreover,
these currents were also prevented by addition of the Ca2
chelator BAPTA to the pipette solution, demonstrating that
they are likely dependent on Ca2 release (Fig. 3D and see Fig.
7A). When N-methyl-D-glucamine replaced extracellular K
and Na, no inward currents could be seen in response to 100
nM NAADP (Fig. 3E). Taken together with the BAPTA studies,
these data are consistent with the inward currents being due to
opening of Ca2-activated cation channels. The NAADP
antagonistNed-19 (100M) also abolished theNAADP-evoked
currents, as shown previously (Fig. 3F) (21). NAADP-evoked
Ca2 release has recently been reported to activate TRPM4
channels in HeLa cells (65), and because this Ca2-activated
nonselective cation channel has been proposed to control insu-
lin secretion (66) along with TRPM5 (67–69), we tested the
effect of 9-phenanthrol, a TRPM4blocker (70), on theNAADP-
evoked currents in  cells. We found that the currents were
inhibited by this drug (Fig. 3G), suggesting a possible involve-
ment of TRPM4 channels.
Importantly, like NAADP, high glucose (15 mM) concentra-
tions also evoked spontaneous inward currents in cells voltage-
clamped at 70 mV (Fig. 3H). These glucose-induced inward
currents were also blocked by Ned-19 (100 M) (Fig. 3I). The
frequencies and amplitudes of the aboveNAADP- and glucose-
evoked currents fromFig. 3,A–I, are summarized in Fig. 3, J and
K, respectively. Taken together, these data raise the exciting
possibility that NAADP-mediated Ca2 release from acidic
storesmaymodulate the glucose-mediatedmembrane currents
that in turn initiate  cell electrical activity and insulin
secretion.
We next examined the effect of intracellular NAADP on the
pancreatic  cell plasma membrane potential. A nonstimula-
tory level of glucose (3 mM) alone (Fig. 4A) had no effect on
resting membrane potential (around70mV). In the presence
of 3 mM glucose, NAADP-AM (60 nM) evoked low amplitude
voltage oscillations that did reach the threshold for action
potential firing (Fig. 4B). At 10 mM glucose, glucose-induced
electrical activity consisting of 30–40-mV action potentials
was observed. Under these conditions, the blockade of NAADP
action with Ned-19 (100 M) resulted in membrane hyperpo-
larization and suppression of electrical activity (Fig. 4C).
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FIGURE 3. NAADP evokes Ca2-dependent inward currents in pancreatic  cells. A, inward currents at70 mV evoked by the infusion of 100 nM NAADP
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If NAADP-evoked Ca2 release is involved in the regulation
of themembrane potential by glucose, pharmacologicalmanip-
ulation of ion fluxes across the endomembranes involvedwould
be predicted to impact on glucose-mediated changes in mem-
brane excitability. It is therefore of interest that bafilomycin
reversibly suppressed glucose-evoked action potentials (Fig.
4D).
Lack of Effects of Ned-19 and Vacuolar Proton Pump Inhibi-
tors on Plasma Membrane Currents and Cell Metabolism and
Validation of Compound Used—Although the profound effects
ofNed-19 and bafilomycin on glucose-mediatedCa2 signaling
and electrical changes above were ascribed to antagonism of
NAADP and abrogation of acidic organelle Ca2 storage, it was
important to rule out other targets that could potentially
account for the effects of these two agents on glucose action.
Ned-19 exerted no significant effects upon glucose metabo-
lism, as indicated by the persistence of glucose-induced
decrease in mitochondrial FAD fluorescence (Fig. 5A). The
inhibitor was also without effect on KATP channel activity; in
the presence of 10 mM glucose, the whole-cell conductance
averaged 0.21  0.04 and 0.20  0.06 nanosiemens in the
absence or presence of Ned-19 (Fig. 5B). By contrast, the com-
bination of the KATP channel activator diazoxide and the mito-
chondrial inhibitor sodium azide (1 mM) resulted in a large
increase in KATP channel activity. Similarly, there was no inhib-
itory effect of Ned-19 on the voltage-gated Ca2 currents; the
peak current during depolarization from70 to 0mV averaged
110 1 pA (n	 10) and 114 1 pA (n	 10) in the absence and
presence of Ned-19, respectively (Fig. 5C). Thus, the suppres-
sion of electrical activity cannot simply be attributed to activa-
tion of KATP channels or inhibition of VDCCs. In addition,
Ned-19waswithout effect onCa2 release induced by the stim-
ulation of muscarinic receptors with acetylcholine (100 M)
(Fig. 5D), which leads to the opening of IP3 receptors and dis-
charge of ER stores (71). These data are therefore consistent
with a high degree of selectivity of Ned-19 as an antagonist of
NAADP and demonstrate that its effects are consistent with a
major role for NAADP-induced Ca2 release in glucose-in-
duced Ca2 signaling.
We next analyzed the effects of bafilomycin on the same
functional parameters. The effects of the latter inhibitor were
independent of alterations in glucose-evoked changes in mito-
chondrialmembrane potential or cell metabolism (Fig. 5, E–G),
VDCCs (Fig. 5H), or modulation of KATP channels (Fig. 5I).
Moreover, in the absence of extracellular Ca2, bafilomycin
increased [Ca2]i after thapsigargin treatment (Fig. 5J), and vice
versa (Fig. 5K), confirming that bafilomycin-sensitive Ca2
stores are distinct from the ER. The application of the lysomo-
tropic agent GPN, a lysosomotropic agent that abrogates Ca2
storage by lysosomes (19, 25), exerted effects that resembled
those of bafilomycin (Fig. 5L), again indicating that a lysosome-
related organelle is the likely source of Ca2 release.
TPC2 Expression and Subcellular Localization in Endocrine
Pancreas—Turning to the molecular targets for NAADP, we
have recently identified TPC2, encoded by the Tpcn2 gene, as a
critical mediator of the NAADP response (29), and we have
shown that it is required to couple stimuli to Ca2 release from
acidic stores (72). This channel is localized on acidic stores, but
not at the ER or plasma membrane, and in particular it co-lo-
calizes with organelles of the endolysosomal system, most
prominently the lysosomes (29). RT-PCR analysis of mouse
islets indicates thatTpcn2 is expressed inmouse islets (Fig. 6A).
Affirming the localization of TPC2 to acidic stores in  cells,
immunolocalization of the endogenous TPC2 in primary
human  cells revealed substantial overlap with immunoreac-
tivity of LAMP1, amajor lysosomalmarker (Fig. 6B). There was
substantially less overlap with immunoreactivity for insulin or
EEA1, used asmarkers for insulin granules (73) and endosomes
(29), respectively. In a complementary approach, TPC2-
mCherry was expressed in MIN6 cells (Fig. 6C). A similar lyso-
somal localization of TPC2-mCherry transfected into this
murine  cell line was seen, but some co-localization with insu-
lin granules could also be seen.
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Glucose and Tolbutamide-evoked Ca2 Responses Are
Reduced in Isolated Pancreatic  Cells from Tpcn2/Mice—
Wenext examined the effects of infusingNAADP (100 nM) into
mouse pancreatic  cells from age-, sex-, and background-
matched wild-type and Tpcn2/ mice via the patch pipette
during standard whole-cell recordings while simultaneously
measuring intracellular Ca2 concentrations (by Fura 2) and
inward membrane currents. In wild-type  cells, NAADP (100
nM) evoked [Ca2]i transients, some of which associated with
transient inward currents (Fig. 7A). However, both NAADP-
evoked Ca2 transients and currents were absent in cells pre-
pared from Tpcn2/ mice (Fig. 7B), mirroring the effect of
Ned-19 on the wild-type cells (Fig. 3F). Detailed morphological
comparison of  cells from Tpcn2/ and wild-type mice by
electron microscopy indicated no substantial differences in
morphology, organelle number, or distribution, including those
of insulin granules (Fig. 7C), making it unlikely that changes in
these parameters were the underlying cause for alterations in
NAADP responses observed in Tpcn2/ null  cells.
Next, we examined the Ca2 responses to glucose of  cells
prepared from wild-type and Tpcn2/mice (Fig. 8, A and B).
In Tpcn2/  cells, glucose-evoked Ca2 transients were
either abolished, reduced in amplitude, or delayed (Fig. 8,B and
C) compared with the robust responses observed in wild-type
cells (Fig. 8, A and C). The average [Ca2]i rises evoked by high
glucose were substantially reduced (but not abolished) in all
Tpcn2/  cells studied (Fig. 8C), although activation of
VDCCs by membrane depolarization by K (45 mM) in the
presence of the KATP channel opener, diazoxide (100 M), still
evoked a large [Ca2]i response (Fig. 8B). Similar results were
obtained from Tpcn1/  cells (Fig. 8, D–F). These studies
indicate that the lysosomal TPC2 and endosomal TPC1 chan-
nels play a significant role in the generation of glucose-induced
Ca2 signals in pancreatic  cells, likely through their modula-
tion of  cell electrical activity.
It has been noted that a minimum concentration of glucose
“fuel” is required for threshold concentrations of the oral hypo-
glycemic agent and KATP inhibitor tolbutamide to mimic the
electrical effects of raised glucose levels inmouse cells (74). In
agreement, we also found that in the absence of glucose (0mM),
tolbutamide (25 M) treatment failed to increase [Ca2]i, in
contrast to the effect in the presence of 3mM glucose. However,
pretreatment with NAADP-AM (60 nM) partially reconstitutes
the Ca2 signal with tolbutamide in the absence of glucose (Fig.
8, G and H). Furthermore, we found that in wild-type mouse 
cells exposed to 3 mM glucose, tolbutamide (25 M) evoked a
rise in [Ca2]i (Fig. 8I), whereas cells from Tpcn2/ mice
failed to respond to tolbutamide.
Role of NAADP and TPC2 in Glucose-induced Insulin
Secretion—Having implicated a key role for NAADP, TPC2,
and lysosomal Ca2 stores in Ca2 signaling and electrical
activity, we finally examined the effect of disrupting NAADP
signalinguponinsulinsecretionitself.Insulinsecretionwasmea-
sured from isolatedwhole islets in response to glucose or 45mM
K. Prior treatment of islets with Ned-19 (100 M) for 5 min
substantially inhibited insulin secretion induced by 15 mM glu-
cose but not by 45 mM K (Fig. 9A). The absence of an effect of
Ned-19 on insulin secretion induced by high K makes it
unlikely that there is a relevant off-target effect of the inhibitor
upon the exocytotic machinery.
We then studied insulin secretion evoked by 20 mM glucose
using the perfused pancreas preparation in wild-type,
Tpcn1/, and Tpcn2/ mice. In the Tpcn1/ and
Tpcn2/ pancreata, both the 1st (the response during the ini-
tial 7 min) and 2nd phase release (insulin secretion once the 1st
phase release had ended) were reduced by
50% (Fig. 9, B–D).
Finally, we performed intraperitoneal blood glucose tests in
fasted TPC knock-out mice in comparison with the corre-
Tpcn2A
TPC2 Insulin Merge 
TPC2 LAMP1 Merge 
TPC2 EEA1 Merge 
B
TPC2 Insulin Merge 
5 µm
1 
2 
TPC2 EEA1 Merge 
10 µm
TPC2 LAMP1 Merge 
10 µm
C
7µm
FIGURE 6. Subcellular localization of TPC2 in human  cells and mouse
MIN6  cells. A, RT-PCR product corresponding to TPC2 mRNAs in the pan-
creas from WT mice with expected product size of 501 bp. B, co-labeling of
endogenous TPC2 and organelle markers in single human  cells. Single
human  cells were fixed and imaged as described under “Experimental Pro-
cedures.” Zoomed images show areas within the yellow boxes. Although little
if any co-localization was observed between TPC2 and insulin or EEA1 stain-
ing, clear overlap was apparent between TPC2 and LAMP1 in well defined
subcellular structures (arrows). C, colabeling of overexpressed TPC2-mCherry
and organelle markers in clonal mouse  cells. MIN6 cells were transfected
with a TPC2-mCherry construct (see under “Experimental Procedures”) and
subsequently fixed and permeabilized. Guinea pig anti-insulin, goat anti-
EEA1, and rat anti-LAMP-1 were revealed as in A. Overlap between TPC2 and
LAMP1-labeled structures is clearly apparent (inset, arrows). Limited overlap
betweenTPC2 and insulinwas observedonly in cells expressinghigh levels of
TPC2-mcherry (cell 1), but little if any co-labeling of insulin and TPC2 was
observed in the majority of cells (cell 2) where TPC2-mCherry levels were
lower.
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sponding strain-matched wild-type animals to examine the
effect of perturbing TPC expression upon glucose homeostasis
in the whole animal. This revealed that in Tpcn1/mice (Fig.
9E) the blood glucose levels peaked at significantly higher levels
than WT, and the time course revealed an impaired glucose
tolerance capacity. In contrast, Tpcn2/ mice (Fig. 9F) were
less affected.
Discussion
This study highlights the importance of NAADP-sensitive
acidic stores and the newly identified endolysosomal channels
TPC1 and TPC2 in Ca2 signaling during stimulus-secretion
coupling in mouse pancreatic  cells. Since its discovery as a
potent Ca2-mobilizing agent in sea urchin egg homogenates
(75), NAADP has been widely demonstrated to evoke Ca2
signals in an extensive range of mammalian cells, including
those of both the endocrine and exocrine pancreas (76).
NAADP is an alternative product ofmultifunctional ADP-ribo-
syl cyclase enzymes, which is also responsible for the synthesis
of the ryanodine receptor-regulating messenger cADPR (46).
Building on early studies suggesting that cADPR is an impor-
tant regulator of Ca2 signaling during secretion-coupling in
pancreatic  cells (77), we now reported that NAADP also
mobilizes Ca2 in pancreatic  cells (16–18).
In contrast to the other two principal mobilizing messengers
IP3 and cADPR, the major target organelles for NAADP in sea
urchin eggs are acidic stores rather than the ER. Pharmacolog-
ical approaches and cell fractionation studies revealed that
NAADP releases Ca2 from a separate organelle to the ER (78,
79), identified as acidic lysosomally related organelles (25). This
principle was later extended to mammalian cells and NAADP
release from acidic stores and has now been established in a
large number cell types (60, 80). In many cells, signaling
domains at lysosome-ER junctions have been observed (81).
Thus, NAADP-evoked Ca2 release from acidic stores may
trigger furtherCa2 release from larger ERCa2 stores through
the mediation of IP3 receptors and ryanodine receptors (59).
Here, we have found that Ca2 signals evoked by the mem-
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brane-permeant NAADP analogue NAADP-AM are from
intracellular stores because they persist in the absence of extra-
cellular Ca2 and that the NAADP antagonist Ned-19 blocks
this effect (Fig. 1).
Comparison of the effects of drugs that effect Ca2 uptake
and storage in different organelles supports a role for acidic
stores rather than the ER as the target of NAADP. Bafilomycin
selectively inhibits vacuolar H pumps that acidify acidic
stores, and it has been shown that Ca2 uptake into acidic
organelles is pH-dependent and probably mediated by
Ca2/H exchange (60). Bafilomycin treatmentwas thus found
to abolish NAADP-AM-evoked Ca2 release (Fig. 1C). In con-
trast, thapsigargin (a SERCA pump inhibitor that blocks Ca2
uptake into the ER) was found to enhance NAADP-AM-in-
duced Ca2 release. This suggests that NAADP-evoked Ca2
release in the  cell does not trigger further Ca2 release
through ER mechanisms. Rather the predominant role of the
ER here is to act to buffer Ca2 rather than as a source for
release, and the functional removal of the ER decreases Ca2
buffering, allowing Ca2 release from acidic stores to increase
further in the cytoplasm. The role of the ER to buffer Ca2
during signaling has also been noted for glucose-evoked Ca2
signals where glucose first decreases cytoplasmic Ca2 due to
increased ATP generation and stimulation of SERCA pumps
(12, 82, 83). Previous studies also support acidic stores as targets
for NAADP. Ca2 indicators targeted to acidic granules or ER
in MIN6 cells showed that NAADP releases Ca2 from acidic
organelles but not the ER (17). Bafilomycin and the lysosomo-
tropic agent GPN abolishes Ca2 release by photolysis of caged
NAADP in MIN6 cells, but it does not affect IP3-evoked Ca2
release (19). In primary mouse  cells, NAADP-evoked Ca2
release was inhibited by GPN, which was shown to lyse acidic
stores selectively (13, 23). The delay in Ca2 responses seen
withNAADP-AM (Figs. 1 and 4)may also be determined partly
by the time for hydrolysis of ester groups by intracellular
endogenous esterases, which varies between cells (51), but the
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delay is probably largely due to initial buffering of Ca2 by the
ER because it was decreased by thapsigargin treatment. In addi-
tion, by analogywith the situation in the ER (83), uptake ofCa2
into acidic stores might be enhanced by glucose-stimulated
ATP production, and because luminal Ca2 sensitizes TPCs to
low NAADP concentrations, this could promote Ca2 release
from these stores (84, 85), an effect that would be enhanced by
removing competing ER stores.
Since the initial reports linkingNAADP-evokedCa2 release
to two-pore channels (29–31), there have been numerous
reports of TPCs playing an essential role inmediatingNAADP-
evoked Ca2 release from acidic stores (58, 86). However,
recent evidence points to a separate NAADP-binding protein
that interacts with TPCs to confer NAADP sensitivity (39).
Indeed, the requirement of NAADP-binding proteins may sug-
gest that under certain circumstances these proteinsmay inter-
act with multiple channel types (87). This may explain a recent
report of the loss of sensitivity of isolated lysosomes to NAADP
(23, 38), and the finding that glucose may apparently still evoke
Ca2 signals in  cells from Tpcn1//Tpcn2/ mice (23),
although it should be noted that the concentrations of
NAADP-AM used in the report by Wang et al. (23) are more
than 3 orders ofmagnitude greater than those found to be effec-
tive here. However, consistent with the data presented here,
these authors (23) also reported that NAADP mobilizes Ca2
from acidic stores in the INS-1  cell line, an effect blocked by
Ned-19, and evoke membrane depolarization and spike gener-
ation in this cell line. We show here that NAADP-evoked Ca2
transients in  cells are abolished in cells prepared from
Tpcn1/ and Tpcn2/mice (Fig. 7, A and B). We found that
endogenous TPC2 proteins in human  cells co-localized with
lysosomalmarkers (Fig. 6B). Interestingly, TPC2 did not appear
in
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to colocalize with insulin granules, which have also been pro-
posed to function as NAADP-sensitive Ca2 stores in  cells
(13, 17).
In addition to mobilizing Ca2 from acidic stores, NAADP
was also found here to evoke plasmamembrane cation currents
and to depolarize the plasma membrane. NAADP applied
through the patch pipette at low concentrations evoked a series
of inward current transients (Fig. 3, A–G). Application of
higher NAADP (100 M) gave no response, consistent with the
bell-shaped concentration-response curve for NAADP in
mammalian systems and paralleling the concentration depen-
dence ofNAADP forCa2 release in cells (Fig. 1A) (16, 18, 20)
and other mammalian cells (58). These currents were blocked
by Ned-19 and by BAPTA, suggesting that they are Ca2-acti-
vated. Their abolition by replacing Na with N-methyl-D-glu-
camine suggests that the currents are cation currents largely
carried byNa ions. Interestingly, a nonselective cation current
has also been reported to be activated by GLP-1 (where GLP-1
is glucagon-like peptide 1), an agonist that has also been
reported to elevate NAADP levels (20), in the HIT-T15  cell
line (88). The identity of the channels responsible has not been
established, but our results with 9-phenanthrol may tentatively
point to some involvement of the TRPM4 channels. NAADP-
evoked Ca2 release has recently been shown to activate
TRPM4 channels in HeLa cells (65). Moreover, TRPM4 and
TRPM5 channels have been proposed to mediate in part a
Ca2-dependent depolarization of the plasmamembrane in the
INS-1  cell line (66–68, 89) and may play a general role as key
components of membrane-based Ca2 oscillators providing
initial cell membrane depolarization for cell activation (90).
The NAADP-evoked currents were found to be coincident with
small NAADP-evoked Ca2 transients (Fig. 7A), and neither
NAADP-evoked Ca2 transients nor currents were observed in
cells from Tpcn2/ mice (Fig. 7B). We propose that these cur-
rents are due to NAADP-evoked Ca2 release from endolyso-
somal stores viaTPC2 channels and that this, in turn, via elevation
of [Ca2]i, leads to Ca2-dependent activation of plasma mem-
brane cation channels, possibly TRPM4 or TRPM5. Activation of
these channels would then result in membrane depolarization.
The finding that application of NAADP-AM elicited a series of
membrane potential spikes (Fig. 4B) is consistent with this sce-
nario and in agreement with a report that NAADP causes mem-
brane depolarization in INS1 cells (23).
To investigate the role of NAADP-mediated Ca2 signaling
in glucose-induced electrical activity and [Ca2]i, four different
approaches were used to block NAADP signaling. These were
as follows: (i) abrogation of Ca2 storage by acidic stores with
vacuolar proton pump inhibitors andGPN; (ii) inhibition of the
NAADP receptor by Ned-19; (iii) self-desensitization of the
NAADP receptor by NAADP; and (iv) knock-out of Tpcn2 and
Tpcn1, genes encoding proposed NAADP target channels.
Intriguingly, high glucose was also found to evoke small Ned-
19-sensitive currents similar to those evoked by pipette appli-
cation of NAADP (Fig. 3H). Thus, NAADP signaling may con-
tribute, at least partly, to bringing themembrane potential from
rest to the threshold for activation of VDCCs (Fig. 10). As has
been recognized for a long time, closure of KATP channels is not
sufficient to explain how glucose depolarizes the pancreatic 
cell; a depolarizing membrane current is also required (7). We
propose that NAADP/TPC1/2-dependent mobilization of
Ca2 from an acidic intracellular store results in activation of
depolarizing cation-conducting plasmalemmal ion channels
and that this brings the membrane potential to the threshold
for action potential firing. This is consistent with our finding
that in the absence of NAADP-evoked Ca2 signals in cells
from Tpcn2/ mice, the KATP channel blocker, tolbutamide,
at threshold concentrations fails to evoke Ca2 signals as seen
in wild-type cells (Fig. 8I). Indeed, it is remarkable that tolbuta-
mide cannot by itself mimic glucose-induced Ca2 signals but
requires NAADP/TPCs. Indeed, tolbutamide will only evoke
Ca2 signals when the acidic vesicle pathway is co-stimulated
either with subthreshold concentrations of NAADP/AM or
with a permissive subthreshold glucose (3 mM) concentration
(Fig. 8, G and H).
The final step in the stimulus-secretion coupling is the exo-
cytosis of insulin-containing granules. In isolated islets, Ned-19
completely blocked glucose-evoked insulin secretion. Ned-19,
however, had no effect on secretion evoked by depolarizing islet
cells with high extracellular K, which bypasses electrical activ-
ity and depolarizes the membrane potential to 
10 mV and
opens the VDCCs. This finding makes it possible to discard the
explanation that Ned-19 inhibits insulin secretion by an off-
FIGURE 10. Proposed model for synergistic effects of NAADP-regulated TPC2 and KATP channels synergizes in glucose-evoked insulin secretion.
NAADP-induced Ca2 release synergizes with the KATP-dependent pathway to depolarize the plasma membrane and activate VDCCs. The ATP-mediated
closure of KATP channels increases membrane resistance, which together with Ca
2-dependent depolarizing currents (possibly TRPM4/5 channels), activated
byNAADP-inducedCa2-release via TPC2 expressedon acidic stores,maydepolarize theplasmamembrane to threshold for VDCCactivation (AS, acidic stores;
NSCC, nonselective cation channel; Rm, membrane resistance; VDCC, voltage-dependent Ca
2 channels; Glc, glucose). In addition, NAADP-induced Ca2-
release together with VDCC-mediated Ca2 influx are both required for exocytosis of insulin granules.
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target effect on the exocytotic machinery. In a more in vivo
setting, glucose-evoked insulin secretion from perfused whole
pancreata from Tpcn2/ and Tpcn1/ mice was investi-
gated. Insulin secretion stimulated by glucose (20mM)was sub-
stantially reduced compared with that from wild-type animals
(Fig. 9B). Thus, we provide evidence that NAADP signaling is
an important regulator of stimulus-secretion coupling in pan-
creatic  cells (Fig. 10).
Surprisingly, Tpcn/ mice are only mildly diabetic as
assessed by glucose tolerance tests (Fig. 9), with a significant
impairment in Tpcn1/ mice. However, a recent study has
implicatedTPC2 as a novel gene for diabetic traits inmice, rats,
and humans (91), with a decrease in fasting glucose and insulin
levels reported in Tpcn2/mice. The effects of knocking out
Tpcn genes in mice may result in complex phenotypes, includ-
ing compensatory mechanisms, with regard to blood glucose
and insulin levels because NAADP-mediated Ca2 release has
been implicated in GLUT4 translocation in murine skeletal
muscle (92). Furthermore, NAADP signaling has been impli-
cated in the action of peroxisome proliferator-activated recep-
tor  agonists in their insulin-sensitizing actions to ameliorate
insulin resistance (93). Future studies with tissue-specific inac-
tivation of these genes will be required to address these
questions.
Although NAADP levels in  cells have been reported to be
increased in response to elevated glucose, and also in response
to the incretin hormone GLP-1 (18, 20), the mechanisms are
not well understood. However, ADP-ribosyl cyclases have been
implicated in NAADP synthesis in  cells (20). Although CD38
is a membrane-bound ecto-enzyme, glucose treatment of 
cells induces endocytosis of CD38 that requires cytoskeletal
changes (22). Inhibition of CD38 internalization with jas-
plakinolide, which promotes actin polymerization, blocks glu-
cose-stimulated NAADP levels and impairs glucose-evoked
Ca2 signaling (22). NAADP synthesis is found to be associated
with lysosomal membrane fractions (20). We have previously
argued that cADPR (and NAADP) synthesis may occur within
the acidic organelles (94). The luminal acidic pH of acidic
organelles would provide an optimal environment for NAADP
synthesis by ADP-ribosyl cyclases (46). We showed that pyri-
dine nucleotides are transported into organelles, and second
messenger products are transported into the cytoplasm to their
site of action (94).
Antibodies to CD38 (95) and a missense mutation in the
CD38 gene (50) have been linked to type 2 diabetes, and this
could potentially be accounted for by reduced NAADP synthe-
sis. Remarkably, in a recent study, it was found that intraperi-
toneal injections of NAADP could restore defective insulin
secretion and blood glucose regulation in db/db mice, an ani-
mal model of type 2 diabetes (24), presumably via the NAADP
transport mechanisms described above.
Conclusions
We propose that NAADP-evoked Ca2 release from acidic
stores via TPC2 or TPC1 channels evokes a small local Ca2
signal that activates Ca2-dependent cation currents in the
plasma membrane. The finding that the membrane currents
evoked by intracellular Ca2 mobilization are blocked by
9-phenanthrol implicates TRPM4 channels in this process.
Additional direct effects of NAADP-evoked Ca2 release on
exocytosis itself cannot be excluded at this stage, with a possible
contribution from exocytotic granules themselves (17, 96). The
NAADP/TPC/acidic organelle pathway represents a new com-
ponent of the glucose-evoked trigger to depolarize the plasma
membrane upon KATP channel closure resulting in VDCC-me-
diated Ca2 influx and insulin secretion (Fig. 10). This new
pathway may offer new targets for novel diabetic therapies.
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